MedPath

Oral Tranexamic Acid in Spinal Surgery

Not Applicable
Conditions
The effect of oral Tranexamic Acid for bleeding in Spinal Surgery.
Hemorrhagic condition, unspecified
D69.9
Registration Number
IRCT20190525043701N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
129
Inclusion Criteria

being in a range of ages 18 to 60
lack of cardiovascular disease
Patients undergoing lumbar and back spine surgery, including discopathies with spinal fusion, and discopathies more than two levels or two-sided spinal cord.

Exclusion Criteria

unwillingness to participate in the study
abnormal bleeding
platelet count less than 150,000 (k)
a history of thrombosis or embolism
severe allergies
using drugs that interact with hemostasis in the blood
high and uncontrolled blood pressure (blood pressure mre than 160/90)
obese people (body mass index more than 30).

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of Bleeding after Oral Administration of Tranexamic acid. Timepoint: Before and after intervention will measure. Method of measurement: The amount of blood collected in cc.
Secondary Outcome Measures
NameTimeMethod
The coagulation tests. Timepoint: Will be checked during and 72 hours after the operation. Method of measurement: According to standard one-stage APTT method.
© Copyright 2025. All Rights Reserved by MedPath